Winship radiation oncologists and researchers led 31 presentations, posters and moderated sessions at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, October 23-26, 2022.
Radiation oncologists and researchers at Winship Cancer Institute of Emory University led 31 presentations, posters and moderated sessions at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, October 23-26, 2022.
They joined colleagues from across the globe to discuss advances in cancer clinical trials and breakthrough science. The 64th annual meeting featured top research and education related to the theme, "AI and EI: Caring for the Patient in a Wireless World."
The ASTRO annual meeting is the world's largest scientific meeting in radiation oncology. The 2022 meeting featured more than 1,700 abstract presentations and clinical trial reports; cancer discoveries from the past year; educational programming focused on diversity, equity and inclusion; and storytelling sessions on patient safety, rural health care, virtual learning and other topics.
Winship-led presentations and sessions include the following:
Saturday, October 22, 2022
- Breakout Group - Best Practices in Health Equity Research for Vulnerable Populations
Presenter: Reshma Jagsi, MD, PhD, FASTRO
Session: Master Class 04 - Master Class: Centering on Equity: Reflecting on Unconscious Bias, Dominant Culture and Privilege - Example 2 - New Technology and RT Delivery in Locally Advanced NSCLC and Esophageal, Examples Include RTOG 1308, NRG-GI006, NRG-LU008
Presenter: Jeffrey D. Bradley, MD, FASTRO
Session: Master Class 02 - Master Class: Clinical Trial Design - Noninferiority Trials
Sunday, October 23, 2022
- EDU 03 - (INTERACTIVE) When Should I Hold Radiation? – Delivery of Radiation with Novel Systemic Agents for Breast Cancer
Moderator: Mylin Torres, MD - Definitive Proton Re-Irradiation for Locally Advanced Lung Cancer in the Immunotherapy Era
Presenter: James Janopaul-Naylor, MD
Abstract: 2844
Session: PQA 01 - Poster Q&A 01 - Lung Cancer and DEIH - NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable Stage IB-III NSCLC
Presenter: Sibo Tian, MD
Abstract: 2877
Session: PQA 01 - Poster Q&A 01 - Lung Cancer and DEIH - Industry Satellite Symposium – Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal is Cure?
Presenter: Kristin Higgins, MD
Monday, October 24, 2022
- SS 07 - Bio 2 - Genomics and Molecular Biomarkers
Moderator: Aparna H. Kesarwala, MD, PhD - Patterns of Treatment Failure in PCNSL
Presenter: Jimmy Patel, MD, PhD
Abstract: 2185
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care - Risk of Late or Recurrent Radiation Necrosis beyond 5 Years from Stereotactic Radiosurgery
Presenter: Neal S. McCall, MD
Abstract: 2146
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care - Multi-Center Quality of Life Outcomes for Patients with Acoustic Neuromas Treated with a Non-Invasive Stereotactic Radiosurgery Instrument and Linear Accelerator-Based Radiosurgery
Presenter: Taylor Jones Corriher, MD, MBA
Abstract: 2095
Session: PQA 02 - Poster Q&A 02 - Central Nervous System and Palliative Care - To Resect or Not to Resect: That is the Question. Resection of Primary Tumors in Oligometastatic Disease
Presenter: Kenneth Cardona, MD
Session: Panel 08 - Sarcoma Tumor Board: Real-Time Management of Challenging Cases in Adult Sarcoma - Session: QP 07 - Bio 3 - Radionuclides, Immunotherapy and Immune Response
Moderator: Zachary S. Buchwald, MD, PhD - Are Diagnostic Computed Tomography Chest Scans Sufficient for Detecting Supraclavicular in Initial Breast Cancer Staging?
Presenter: Jolinta Y. Lin, MD
Abstract: 2015
Session: PQA 03 - Poster Q&A 03 - Breast Cancer and Nonmalignant Disease - Current Understanding of Cervicovaginal Microbiome in Gynecologic Cancers
Presenter: Lauren Colbert, MD, MSCR
Session: International 05 - Human Microbiome Project and Radiation: Rationale, Clinical Implications and Future Perspective - SS 14 - Bio 4 - Radiation-Induced Changes in Macrophage Biology
Moderator: Lauren Colbert, MD, MSCR - Radiotherapy Use and Locoregional Recurrence Rates on SWOG 1007, a US Cooperative Group Trial Enrolling Patients with Favorable-Risk Node-Positive Breast Cancer
Presenter: Reshma Jagsi, MD, PhD, FASTRO
Abstract: 172
Session: SS 13 - Breast 2 - Biology and Outcomes
Tuesday, October 25, 2022
- Patient Reported Outcomes: Have They Changed Evaluation of Treatment Techniques?
Presenter: Deborah W. Bruner, PhD, RN, FAAN
Session: Joint 03 - ASTRO/ESTRO Joint Session - Personalized Care-Learning from the Patient - The LMIC Experience and Lessons Learned from Limited Resources
Moderator and Presenter: Natia Esiashvili, MD
Session: Joint 04 - (INTERACTIVE) ASTRO/PROS Joint Session - Lessons Learned from Treating Children During the COVID-19 Pandemic - Toxicity Following Multimodal Treatment of Pancreatic Cancer
Presenter: Riley Brackin
Abstract: 2426
Session: PQA 05 - Poster Q&A 05 - Gastrointestinal Cancer and Sarcoma - OSH 09 - onDemand Science Highlights 9 - Pediatrics
Discussant: Bree R. Eaton, MD - 2477 RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High Risk Prostate
Presenter: Deborah W. Bruner, PhD, RN, FAAN
Abstract: 2477
Session: Poster Q&A 06 - Genitourinary Cancer, Patient Safety, and Nursing - Randomized Trial of 18F-fluciclovine vs. 68Ga-PSMA PET/CT Guided Post-Prostatectomy Radiotherapy: Interim Volumetric and Toxicity Analyses
Presenter: Ashesh Jani, MD, FASTRO
Abstract: 2489
Session: Poster Q&A 06 - Genitourinary Cancer, Patient Safety, and Nursing - Patient-Specific Self-Supervised Resolution-Enhancing Network for High-Resolution MR Imaging in MRI-Guided Radiotherapy
Presenter: Xiaofeng Yang, PhD
Abstract: 2235
Session: PQA 07 - Poster Q&A 07 - Hematologic Malignancies and Digital Health Innovation - Lesion Segmentation Using Convolutional Neural Network for PET/CT-Guided Salvage Post-Prostatectomy Radiotherapy
Presenter: Xiaofeng Yang, PhD
Abstract: 2254
Session: PQA 07 - Poster Q&A 07 - Hematologic Malignancies and Digital Health Innovation - Characteristics, Treatment and Outcomes of Patients with Primary Urethral Cancer: A Multi-Center Review over Two Decades
Presenter: David C. Qian, MD, PhD
Abstract: 2597
Session: PQA 08 - Poster Q&A 08 - Gynecological Cancer, Pediatric Cancer, and Professional Development - Characteristics, Treatment and Outcomes of Patients with Primary Urethral Cancer: A Multi-Center Review over Two Decades
Presenter: Sagar A. Patel, MD
Abstract: 235
Session: SS 25 - GU 5 - Bladder and Kidney Preservation
Wednesday, October 26, 2022
- Challenging Cases in GU Malignancies: Incorporating Imaging Findings Into Personalized Treatment Recommendations
Presenter: Ashesh Jani, MD, FASTRO
Session: Panel 22 - (INTERACTIVE) Incorporating Imaging Findings Into Personalized Treatment Recommendations for Prostate Cancer: A Case-Based Discussion - Role of PARP in Cancer Cells and Current Clinical Indications
Moderator and Presenter: Aparna H. Kesarwala, MD, PhD
Session: EDU 32 - Don’t Be Afraid of the PARP: Current Clinical Role of PARP Inhibitors - A PI3Kinase/Akt/mTOR Gene Expression Signature Predicts for Recurrence in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
Presenter: Nikhil Sebastian, MD
Abstract: 1125
Session: QP 21 - Lung 3 - Optimizing Radiation Dose, Volume, and Concomitant Systemic Agents - Knowledge-Based Treatment Planning Model Improves Organ-at-Risk Sparing and Plan Consistency across Clinics for Prostate Radiation Therapy
Presenter: Jiahan Zhang, PhD
Abstract: 3318
Session: PQA 10 - Poster Q&A 10 - Physics - Session: QP 22 - CNS 3 - CNS Clinical Quick Pitches
Moderator: Jim Zhong, MD
